Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-57,000
Closed -$3K 4956
2022
Q3
$3K Sell
57,000
-6,400
-10% -$15.9K ﹤0.01% 3998
2022
Q2
$8K Sell
63,400
-77,400
-55% -$185K ﹤0.01% 3384
2022
Q1
$40K Buy
140,800
+69,900
+99% +$246K ﹤0.01% 2438
2021
Q4
$16K Buy
70,900
+3,000
+4% +$22.7K ﹤0.01% 3308
2021
Q3
$61K Sell
67,900
-65,100
-49% -$478K ﹤0.01% 2352
2021
Q2
$126K Buy
133,000
+112,300
+543% +$948K 0.01% 1682
2021
Q1
$10K Buy
+20,700
New +$138K ﹤0.01% 3817

Other funds holding OCGN

Cutler Group's OCGN Position: Q1 2023 in Review

Cutler Group sold out of Ocugen (OCGN) in Q1 2023, closing a stake of 3,500 shares — an estimated $4K sold.

Cutler Group first reported a position in OCGN in Q1 2021 and held it in 8 quarters. The position peaked at $63K in Q1 2021. 103 funds tracked by Wall St. Rank hold OCGN as of Q1 2023.

  • Cutler Group reported no remaining Ocugen position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 3,500 Ocugen shares in Q1 2023, an estimated $4K.
  • Cutler Group first reported a position in Ocugen in Q1 2021 and held it in 8 quarters.
  • Cutler Group's Ocugen position peaked at $63K in Q1 2021.
  • 103 funds tracked by Wall St. Rank held Ocugen as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.